Document Classification

Section Type: METHODS

Text: Patients with clinical stage II or III rectal cancer who were undergoing preoperative RT (45 Gy in 25 fractions over 5 weeks plus a boost of 5. 4 Gy to 10. 8 Gy in three to six daily fractions) were randomly assigned to one of the following chemotherapy regimens : continuous intravenous infusional fluorouracil (CVI FU ; 225 mg/m (2), 5 days per week), with or without intravenous oxaliplatin (50 mg/m (2) once per week for 5 weeks) or oral capecitabine (825 mg/m (2) twice per day, 5 days per week), with or without oxaliplatin (50 mg/m (2) once per week for 5 weeks).